Advertisement
Diagnostics
Subscribe to Diagnostics
View Sample

FREE Email Newsletter

Seventh Sense Biosystems Announces Initiation of Registration Trial for Painless TAP Blood Collection Device

April 2, 2013 7:30 am | by The Associated Press | News | Comments

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Apr 2, 2013--Seventh Sense Biosystems, a privately held medical device company developing integrated blood micro-collection and analysis platforms, announced today that it has initiated a registration trial for its painless TAP™ (Touch Activated Phlebotomy) blood...

LabCorp Announces the Availability of Expanded Services for Inflammatory Bowel Disease

April 1, 2013 6:15 am | by The Associated Press | News | Comments

BURLINGTON, N.C.--(BUSINESS WIRE)--Apr 1, 2013--Laboratory Corporation of America ® Holdings (LabCorp ® ) (NYSE: LH) announced today the availability of an expanded testing menu to help clinicians diagnose, treat and monitor the course of Inflammatory Bowel Disease (IBD). Gastrointestinal (GI)...

New Metabolite-based Diagnostic Test Could Help Detect Pancreatic Cancer Early

March 29, 2013 9:00 am | by AACR | News | Comments

A new diagnostic test that uses a scientific technique known as metabolomic analysis may be a safe and easy screening method that could improve the prognosis of patients with pancreatic cancer through earlier detection. Researchers examined the utility of metabolomic analysis as a diagnostic method for pancreatic cancer and then validated the new approach...

Advertisement

Neuro Kinetics Releases New Version of VEST(TM) Control & Analysis Software

March 28, 2013 5:03 pm | by The Associated Press | News | Comments

Medical device manufacturer Neuro Kinetics, Inc., (NKI) will showcase the latest version of its VEST™ control and analysis software at the American Academy of Audiology's AudiologyNOW! 2013 conference next week in Anaheim, California. The...

How to Make a Computer from a Living Cell

March 28, 2013 4:02 pm | by Massachusetts Institute of Technology | News | Comments

If biologists could put computational controls inside living cells, they could program them to sense and report on the presence of cancer, create drugs on site as they’re needed, or dynamically adjust their activities in fermentation tanks used to make drugs and other chemicals. Now researchers at Stanford University have developed a way to make genetic parts that can perform the logic calculations that might someday control such activities.

MicroRNA Detection on the Cheap

March 28, 2013 3:58 pm | by MIT | News | Comments

Current methods of detecting microRNA (miRNA) — gene-regulating molecules implicated in the onset of various diseases — can be time-consuming and costly: The custom equipment used in such tests costs more than $100,000, and the limited throughput of these systems further hinders progress.

T2 Biosystems' Series E Round Reaches $40M

March 28, 2013 11:11 am | by Mass Device | News | Comments

T2 Biosystems reels in a $40 million Series E round for its MR-based molecular diagnostic test for the Candida fungus, a leading cause of hospital-acquired infections. T2 Biosystems, which is developing a diagnostic device that uses magnetic resonance technology to deliver nearly instant test results, said it raised a $40 million Series E round it plans to use for its T2Candida test for a common cause of hospital-acquired infections.

TE-Cooled MPPC Module

March 27, 2013 10:03 am | by MDT Staff | Product Releases | Comments

Hamamatsu Photonics introduce the new C11208 MPPC module which integrates the S11028 series MPPC, a pixelated silicon avalanche photodiode operated in Geiger-mode, with the addition of a high performance thermoelectric cooler.

Advertisement

Lyme Disease and Nanotubes, Paving Way for Diagnostic Device

March 27, 2013 9:45 am | by University of Pennsylvania | News | Comments

Early diagnosis is critical in treating Lyme disease. However, nearly one quarter of Lyme disease patients are initially misdiagnosed because currently available serological tests have poor sensitivity and specificity during the early stages of infection.

Trovagene Launches Urine-Based HPV Test

March 27, 2013 5:07 am | by Bio-Medicine.Org | News | Comments

SAN DIEGO , March 27, 2013 /- Trovagene, Inc. (NASDAQ:  TROV), today announced the commercial availability of its urine-based HPV-HR (high-risk) assay, a molecular human papillomavirus (HPV) test. The non-invasive test is designed to accurately identify the presence or absence of 15 known high-risk HPV strains using proprietary DNA sequences.

Guidance for Industry and Food and Drug Administration Staff - Establishing the Performance Characteristics of In Vitro Diagnostic Devices for the Detection of Antibodies to Borrelia burgdorferi

March 27, 2013 12:00 am | by U.S. Food & Drug Administration | News | Comments

FDA is issuing this guidance to provide industry and agency staff with recommendations for studies to establish the analytical and clinical performance of in vitro diagnostic devices (IVDs) intended for the detection of antibodies to Borrelia burgdorferi.

More Light! – for Medicine

March 26, 2013 12:27 pm | by Forschungsverbund Berlin e.V. | News | Comments

PET scan, CT, and MRI are almost standard in today’s diagnostics – highly developed and very sophisticated. Although more capable and less cost-intensive, laser-optical diagnosis methods are, up to now, far less prevalent. FAMOS is aiming to change this.

Quinte Health Care Chooses Amcom Software for Critical Test Results Management

March 26, 2013 9:00 am | by The Associated Press | News | Comments

MINNEAPOLIS--(BUSINESS WIRE)--Mar 26, 2013--Amcom Software, Inc. today announced Quinte Health Care (QHC) will use the Amcom® Critical Test Results Management (CTRM) solution to save time and improve patient safety and quality of care. The Ontario, Canada-based organization selected Amcom to...

Advertisement

UCLA Relies on Breakthrough ‘Big Data’ Technology from IBM To Help Patients with Traumatic Brain Injuries

March 25, 2013 11:20 pm | by IBM | News | Comments

IBM, and Excel Medical Electronics (EME) are collaborating with the UCLA Department of Neurosurgery in a study to test the effectiveness of a real-time alarm intended to predict rising brain pressure in patients with traumatic brain injuries. The experimental system uses big data analytics software developed by IBM Research and EME that analyzes in real-time streams of vital signs continuously collected from the bedside monitor...

OraQuick® Launches "Make Knowing Your Thing Today" Campaign to Promote the Importance of Knowing Your HIV Status

March 25, 2013 2:34 pm | by PR Newswire | News | Comments

LOS ANGELES, March 25, 2013 /PRNewswire/ -- OraSure Technologies, Inc. (NASDAQ:OSUR), maker of the OraQuick® In-Home HIV Test, announced today the launch of a nationwide awareness campaign to encourage everyone to learn their HIV status. The campaign, "Make Knowing Your...

FDA Approves GE Healthcare's AdreView™ (Iobenguane I 123 Injection) for Cardiac Risk Evaluation in Heart Failure Patients

March 22, 2013 7:07 pm | by The Associated Press | News | Comments

GE Healthcare today announced the U.S. Food and Drug Administration (FDA) approval of a new indication for AdreView™ (Iobenguane I 123 Injection), the first and only FDA approved molecular imaging agent to link nerve function in the heart to a patient’s mortality risk.

Lantheus Medical Imaging Focuses on Growth, Takes Steps to Reduce Expenses

March 21, 2013 3:30 pm | by The Associated Press | News | Comments

NORTH BILLERICA, Mass.--(BUSINESS WIRE)--Mar 21, 2013--Lantheus Medical Imaging, Inc., a global leader in developing, manufacturing and distributing innovative diagnostic imaging agents, today announced that under its new leadership team led by Jeff Bailey, President and Chief Executive Officer,...

Leading U.S. Pulmonologists to Investigate Impact of Mauna Kea Technologies' Cellvizio on Lung Cancer Diagnosis

March 21, 2013 12:45 pm | by The Associated Press | News | Comments

Mauna Kea Technologies (NYSE Euronext: MKEA), leader in the optical biopsy market and developer of Cellvizio®, the fastest way to see cancer, announced today that it has launched a registry study to determine the impact of Cellvizio optical biopsies on the diagnosis of lung cancer, the leading cause of cancer death in the world.

WPI and UMass Medical School Team Up to Improve Healthcare Delivery

March 21, 2013 11:22 am | by Worcester Polytechnic Institute | News | Comments

The Healthcare Delivery Institute is a multi-disciplinary organization that includes more than 20 research teams at WPI, external healthcare providers, and industry partners, all working to address the national and global challenge of creating the future of healthcare delivery.

Hologic's 3D Mammography Technology to be the "New Standard of Care," According to Healthcare Research Firm KLAS

March 19, 2013 5:27 pm | by PR Newswire | News | Comments

BEDFORD, Mass., March 19, 2013 /PRNewswire/ -- Hologic, Inc. (Hologic or the Company) (NASDAQ: HOLX), a leading developer, manufacturer and supplier of premium diagnostics products, medical imaging systems and surgical products dedicated to serving the healthcare needs of women, announced...

Douglas Harrington, MD Addresses Select Group of Physicians Regarding Latest Advances in Cardiovascular Risk Assessment

March 19, 2013 2:44 pm | by The Associated Press | News | Comments

SAN FRANCISCO--(BUSINESS WIRE)--Mar 19, 2013--Aviir Inc., a biotechnology company dedicated to enhanced detection and prevention of cardiovascular disease through innovative diagnostic tests, announced that Douglas Harrington, MD, Clinical Professor of Pathology at USC and Aviir, Inc. CEO,...

DiaTech Oncology Test Shows Improved Results, New Hope for Leukemia Patients

March 19, 2013 8:37 am | by The Associated Press | News | Comments

NASHVILLE, Tenn.--(BUSINESS WIRE)--Mar 19, 2013--Results of clinical trials published this month in the medical peer-review journal showed overall survival rate improved 257% for certain groups of leukemia patients when physicians used DiaTech Oncology’s test to help determine chemotherapy...

Athena Diagnostics Announces New Genetic Testing Services for Rare Neurological Disorders

March 18, 2013 1:07 pm | by Bio-Medicine.Org | News | Comments

Athena Diagnostics, a leader in neurological diagnostics, today announced the clinical availability of new genetic tests to aid the detection of several rare neurological disorders, including hereditary neuropathy, neuromuscular disease, epilepsy and certain movement disorders. The lab-developed tests are available...

Quidel and Life Technologies Receive FDA Clearance for Clostridium difficile Assay and Quantstudio(TM) DX and 7500 Fast DX Real-Time PCR Instruments

March 18, 2013 8:00 am | by The Associated Press | News | Comments

Quidel Corporation (NASDAQ: QDEL) and Life Technologies Corporation (NASDAQ: LIFE) announced today that they received 510(k) clearances from the United States Food and Drug Administration (FDA) to market the Quidel Molecular Direct C. difficile Assay with Life Technologies'...

Pathwork Diagnostics Collaborating with Kindstar Global to Provide Tissue of Origin Test in China

March 14, 2013 11:00 am | by The Associated Press | News | Comments

REDWOOD CITY, Calif.--(BUSINESS WIRE)--Mar 14, 2013--Pathwork Diagnostics, Inc., the innovator of the Pathwork Tissue of Origin Test and a pioneer in creating genomics-based diagnostics in oncology, announced today that it has entered into an agreement with Kindstar Global (Kindstar) to provide...

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading